HIGHLIGHTS
- who: Gaber El-Saber Batiha from the (UNIVERSITY) have published the article: Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship, in the Journal: (JOURNAL)
- what: The aim of this study was to reveal the connection between PAI-1 and the pathogenesis of GDM and related complications. The present review had several limitations including paucity of clinical studies and sequential levels of PAI-1 in the different trimesters were not revealed.
SUMMARY
Plasminogen activator inhibitor 1 (PAI-1) also known as serpin E1 or endothelial plasminogen activator inhibitor which is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.